title: Mitochondrial dysfunction following perinatal exposure to nucleoside analogues.
authors.affiliation: Unité d'Immunologie Hématologie pédiatrique, Hôpital Necker Enfants-Malades, Assistance Subligne-Hopitaux de Paris et EA 3620 Université Paris 5, 149 Rue de Sèvres, 75015 Paris, France. blanche@necker.fr
authors.forename: Stéphane
authors.initials: S
authors.lastname: Blanche
authors.forename: Marc
authors.initials: M
authors.lastname: Tardieu
authors.forename: Valérie
authors.initials: V
authors.lastname: Benhammou
authors.forename: Josiane
authors.initials: J
authors.lastname: Warszawski
authors.forename: Pierre
authors.initials: P
authors.lastname: Rustin
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects*; D002648:Child; D005260:Female; D015658:HIV Infections / Q000517:prevention & control*; D015497:HIV-1; D006801:Humans; D007231:Infant, Newborn; D019259:Lamivudine / Q000009:adverse effects; D028361:Mitochondrial Diseases / Q000139:chemically induced* / Q000175:diagnosis; D009422:Nervous System Diseases / Q000139:chemically induced; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D011297:Prenatal Exposure Delayed Effects; D015215:Zidovudine / Q000009:adverse effects
chemical_list: D019380:Anti-HIV Agents; D019259:Lamivudine; D015215:Zidovudine